0000899243-22-004186.txt : 20220202 0000899243-22-004186.hdr.sgml : 20220202 20220202171545 ACCESSION NUMBER: 0000899243-22-004186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vavricka John CENTRAL INDEX KEY: 0001829630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39661 FILM NUMBER: 22584760 MAIL ADDRESS: STREET 1: C/O ATEA PHARMACEUTICALS, INC. STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 125 SUMMER STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-31 0 0001593899 Atea Pharmaceuticals, Inc. AVIR 0001829630 Vavricka John 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 0 1 0 0 Chief Commercial Officer Stock Option (Right to Buy) 7.14 2022-01-31 4 A 0 135000 0.00 A 2032-01-30 Common Stock 135000 135000 D The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. /s/ Andrea Corcoran, as Attorney-in-Fact for John Vavricka, Andrea Corcoran, as Attorney-in-Fact for John Vavricka 2022-02-02